Jolie Ringash, MD, MSc, FRCPC

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

https://orcid.org/0000-0002-7337-0411
Keywords: radiation therapy, gastrointestinal cancer, intensity-modulated radiotherapy, clinical trials, quality of life
  • Upper abdominal organ motion
  • Cancer survivorship
  • Quality of life in patients with enteral feeding tubes
  • Quality of life issues for patients with head and neck cancers: hyperfractionated/accelerated radiation therapy and chemoradiation therapy
  • Adjuvant therapy for stomach cancer
  • Intensity-modulated radiation therapy for stomach cancer

Related Links

Associated Program(s)
Re: Misuse of Quality of Life Evaluation in Oncology Studies.
Pract Radiat Oncol. 2019 Nov;9(6):503
Ringash J
The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
So N, McDowell LJ, Lu L, Xu W, Rock K, Waldron J, Bernstein LJ, Chan HB, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J
Patient-reported symptoms for esophageal cancer patients undergoing curative intent treatment.
Ann Thorac Surg. 2019 Sep 21;:
Gupta V, Allen-Ayodabo C, Davis L, Zhao H, Hallet J, Mahar AL, Ringash J, Kidane B, Darling G, Coburn NG
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Alfaraj F, Craig T, Huang SH, O'Sullivan B, Su J, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Hansen A, de Almeida J, Perez-Ordonez B, Weinreb I, Tong L, Xu W, Hope A
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Eur J Cancer. 2019 Jul 19;118:112-120
Oliva M, Huang SH, Xu W, Su J, Hansen AR, Bratman SV, Ringash J, Jang R, Cho J, Bayley A, Hope AJ, Chen E, Giuliani M, Waldron J, Weinreb I, Perez-Ordonez B, Chepeha D, Kim J, O Sullivan B, Siu LL, Spreafico A
Readmission rates following esophageal cancer resection are similar at regionalized and non-regionalized centers: A population-based cohort study.
J Thorac Cardiovasc Surg. 2019 May 03;:
Gupta V, Bubis L, Kidane B, Mahar AL, Ringash J, Sutradhar R, Darling GE, Coburn NG
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Hosni A, Huang SH, Chiu K, Xu W, Su J, Lu L, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
Billfalk-Kelly A, Yu E, Su J, O'Sullivan B, Waldron J, Ringash J, Bartlett E, Perez-Ordonez B, Weinreb I, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Hansen AR, de Almeida J, Tong L, Xu W, Huang SH
Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer.
Curr Oncol. 2018 Dec;25(6):366-370
Natori A, Chan BA, Sim HW, Ma L, Yokom DW, Chen E, Liu G, Darling G, Swallow C, Brar S, Brierley J, Ringash J, Wong R, Kim J, Rogalla P, Hafezi-Bakhtiari S, Conner J, Knox J, Elimova E, Jang RW
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Lancet. 2018 Nov 15;:
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan...

Pages


 

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Professor, Department of Radiation Oncology, University of Toronto
Professor, Department of Health Policy, Management & Evaluation, University of Toronto
Staff Radiation Oncologist, Princess Margaret Hospital